Sigma-1 and Sigma-2 Receptor Modulators as Potential Therapeutics for Alzheimer's Disease.
作者信息
Kargbo Robert B
机构信息
Usona Institute, 277 Granada Drive, San Luis Obispo, California 93401-7337, United States.
出版信息
ACS Med Chem Lett. 2021 Jan 21;12(2):178-179. doi: 10.1021/acsmedchemlett.1c00002. eCollection 2021 Feb 11.
Abstract
摘要
相似文献
1
Sigma-1 and Sigma-2 Receptor Modulators as Potential Therapeutics for Alzheimer's Disease.
ACS Med Chem Lett. 2021 Jan 21;12(2):178-179. doi: 10.1021/acsmedchemlett.1c00002. eCollection 2021 Feb 11.
2
Roles of sigma-1 receptors in Alzheimer's disease.
Int J Clin Exp Med. 2015 Apr 15;8(4):4808-20. eCollection 2015.
3
Sigma-2 Receptor as a Potential Drug Target.
Curr Med Chem. 2021;28(21):4172-4189. doi: 10.2174/0929867327666200902172615.
4
Improving Alzheimer's Disease-Related Cognitive Deficits with sigma1 Receptor Agonists.
Drug News Perspect. 2002 Dec;15(10):617-625. doi: 10.1358/dnp.2002.15.10.740241.
5
From dopamine 4 to sigma 1: Synthesis, SAR and biological characterization of a piperidine scaffold of σ1 modulators.
Eur J Med Chem. 2022 Dec 15;244:114840. doi: 10.1016/j.ejmech.2022.114840. Epub 2022 Oct 14.
6
Sigma receptor modulators: a patent review.
Expert Opin Ther Pat. 2013 May;23(5):597-613. doi: 10.1517/13543776.2013.769522. Epub 2013 Feb 7.
7
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
PLoS One. 2014 Nov 12;9(11):e111899. doi: 10.1371/journal.pone.0111899. eCollection 2014.
8
Sigma-2 Receptor-A Potential Target for Cancer/Alzheimer's Disease Treatment via Its Regulation of Cholesterol Homeostasis.
Molecules. 2020 Nov 20;25(22):5439. doi: 10.3390/molecules25225439.
9
Activation of the sigma-1 receptor attenuates blood-brain barrier disruption by inhibiting amyloid deposition in Alzheimer's disease mice.
Neurosci Lett. 2022 Mar 23;774:136528. doi: 10.1016/j.neulet.2022.136528. Epub 2022 Feb 12.
10
The Sigma Receptors in Alzheimer's Disease: New Potential Targets for Diagnosis and Therapy.
Int J Mol Sci. 2023 Jul 27;24(15):12025. doi: 10.3390/ijms241512025.
引用本文的文献
1
Recent Advances in the Development of Sigma Receptor (Radio)Ligands and Their Application in Tumors.
ACS Pharmacol Transl Sci. 2025 Mar 7;8(4):951-977. doi: 10.1021/acsptsci.4c00711. eCollection 2025 Apr 11.
2
Microarray-Based Methodology for Lipid Profiling, Enzymatic Activity, And Binding Assays in Printed Lipid Raft Membranes from Astrocytes and Neurons.
Anal Chem. 2025 Jan 14;97(1):86-95. doi: 10.1021/acs.analchem.4c02421. Epub 2024 Dec 24.
3
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity.
RSC Med Chem. 2023 Jul 26;14(9):1734-1742. doi: 10.1039/d3md00291h. eCollection 2023 Sep 19.
4
The Sigma Receptors in Alzheimer's Disease: New Potential Targets for Diagnosis and Therapy.
Int J Mol Sci. 2023 Jul 27;24(15):12025. doi: 10.3390/ijms241512025.
5
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting.
Int J Mol Sci. 2023 Jun 2;24(11):9684. doi: 10.3390/ijms24119684.
6
Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases.
Int J Mol Sci. 2023 Mar 26;24(7):6251. doi: 10.3390/ijms24076251.
7
Therapeutic Properties of Ayahuasca Components in Ischemia/Reperfusion Injury of the Eye.
Biomedicines. 2022 Apr 26;10(5):997. doi: 10.3390/biomedicines10050997.
8
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.
J Med Chem. 2021 Jun 24;64(12):7926-7962. doi: 10.1021/acs.jmedchem.0c02265. Epub 2021 Jun 2.
本文引用的文献
1
and sigma 1 receptor imaging studies in different disease states.
RSC Med Chem. 2020 Oct 8;12(2):154-177. doi: 10.1039/d0md00186d. eCollection 2021 Mar 4.
2
Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease.
Neuropharmacology. 2021 Jun 1;190:108342. doi: 10.1016/j.neuropharm.2020.108342. Epub 2020 Oct 9.
3
Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis.
Br J Pharmacol. 2021 Mar;178(6):1336-1352. doi: 10.1111/bph.15224. Epub 2020 Sep 1.
4
The Biological Function of Sigma-2 Receptor/TMEM97 and Its Utility in PET Imaging Studies in Cancer.
Cancers (Basel). 2020 Jul 13;12(7):1877. doi: 10.3390/cancers12071877.
5
Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases.
Front Neurosci. 2019 Aug 28;13:862. doi: 10.3389/fnins.2019.00862. eCollection 2019.
6
Allosteric Modulators of Sigma-1 Receptor: A Review.
Front Pharmacol. 2019 Mar 19;10:223. doi: 10.3389/fphar.2019.00223. eCollection 2019.
Zotero 插件